Exact Sciences Corporation EXAS
Set alert
104.91 USD 0.00 0.00%
As of Mar 23, 9:30 AM ET
104.91 Day range 104.91
62.39 52-week range 104.98
- YTD
- +3.30%
- 1 year
- +129.96%
- Open
- 104.91
- Prev close
- 104.91
- Mkt cap
- 20.03B
- Vol
- 21.56M
- Avg vol
- 3.05M
- EPS
- -1.10
- P/E
- -188.59
- Div yield
- 0.00%
More statistics
- Low
- 104.91
- High
- 104.91
- Beta
- 1.44
- Inst. own
- 86.48%
- Dividend
- 0.00
2Y chart
Events in this range
- Nov 5, 2024Earnings: -0.21; estimate -0.19589; surprise -7.2%
- Feb 19, 2025Earnings: -0.06; estimate -0.29; surprise 79.31%
- May 1, 2025Earnings: -0.54; estimate -0.37; surprise -45.95%
- Aug 6, 2025Earnings: 0.22; estimate -0.02; surprise 1200%
- Nov 3, 2025Earnings: 0.24; estimate -0.06122; surprise 492.03%
- Nov 24, 2025Downgrade: Jefferies · Buy → Hold
- Nov 24, 2025Downgrade: Benchmark · Buy → Hold
- Nov 25, 2025Downgrade: Canaccord Genuity · Buy → Hold
- Nov 28, 2025Downgrade: Stifel · Buy → Hold
- Jan 5, 2026Downgrade: Evercore ISI Group · Outperform → In-Line
- Jan 20, 2026Downgrade: Mizuho · Outperform → Neutral
- Feb 13, 2026Earnings: -0.45; estimate -0.10793; surprise -316.94%
Signals (80)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Mar 20, 2026 | 7 months ago |
| RSI: Overbought | Mar 20, 2026 | 7 months ago |
| RSI: Overbought | Mar 9, 2026 | 7 months ago |
| RSI: Overbought | Mar 4, 2026 | 8 months ago |
| RSI: Overbought | Feb 5, 2026 | 8 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 19, 2025 | 11 months ago |
| RSI: Overbought | Nov 19, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 3, 2025 | 12 months ago |
| RSI: Overbought | Oct 31, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| RSI: Overbought | Sep 5, 2025 | 1 year ago |
| SMA: Bullish | Sep 4, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 15, 2025 | 1 year ago |
| RSI: Oversold | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 27, 2025 | 1 year ago |
| SMA: Bearish | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | Jun 11, 2025 | 1 year ago |
| SMA: Bullish | Jun 10, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| RSI: Overbought | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| RSI: Overbought | May 15, 2025 | 1 year ago |
| RSI: Overbought | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 24, 2025 | 1 year ago |
| SMA: Bearish | Jan 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 13, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 18, 2024 | 1 year ago |
| SMA: Bearish | Dec 12, 2024 | 1 year ago |
| SMA: Bullish | Dec 11, 2024 | 1 year ago |
| SMA: Bearish | Dec 5, 2024 | 1 year ago |
| SMA: Bullish | Dec 4, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 6, 2024 | 1 year ago |
| RSI: Oversold | Nov 6, 2024 | 1 year ago |
| MACD: Sell Signal | Sep 26, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 12, 2024 | 2 years ago |
| RSI: Overbought | Aug 29, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 26, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 1, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 30, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 30, 2024 | 2 years ago |
| SMA: Bearish | Jul 26, 2024 | 2 years ago |
| SMA: Bullish | Jul 16, 2024 | 2 years ago |
| RSI: Oversold | Jun 14, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 12, 2024 | 2 years ago |
| RSI: Oversold | Jun 7, 2024 | 2 years ago |
| RSI: Oversold | May 29, 2024 | 2 years ago |
| MACD: Sell Signal | May 28, 2024 | 2 years ago |
| MACD: Buy Signal | May 22, 2024 | 2 years ago |
| MACD: Sell Signal | May 14, 2024 | 2 years ago |
Key statistics
- Market cap
- 20.03B
- Enterprise value
- 21.59B
- Trailing P/E
- -188.59
- PEG ratio
- -2.15
- Price / sales
- 7.88
- Price / book
- 8.29
- Beta
- 1.44
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -4.20%
- Total cash
- 0
- Total debt
- 13
- Return on equity
- -4.34%
Analyst view
Price target (mean) —
Ratings (0m) 12 1 buy · 11 hold · 0 sell
- Strong buy1
- Buy0
- Hold11
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.05.
Financials — quick view
EXAS Revenue — quarterly 878.38M
EXAS Net income — quarterly -85.95M
EXAS EPS — quarterly -0.45
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2026 | Dec 31, 2025 | -0.10793 | -0.45 | -0.34 | -316.94% |
| Nov 3, 2025 | Sep 30, 2025 | -0.06122 | 0.24 | +0.30 | +492.03% |
| Aug 6, 2025 | Jun 30, 2025 | -0.02 | 0.22 | +0.24 | +1,200.00% |
| May 1, 2025 | Mar 31, 2025 | -0.37 | -0.54 | -0.17 | -45.95% |
| Feb 19, 2025 | Dec 31, 2024 | -0.29 | -0.06 | +0.23 | +79.31% |
| Nov 5, 2024 | Sep 30, 2024 | -0.19589 | -0.21 | -0.01 | -7.20% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 20, 2026 | Mizuho | down | Outperform | Neutral |
| Jan 5, 2026 | Evercore ISI Group | down | Outperform | In-Line |
| Nov 28, 2025 | Stifel | down | Buy | Hold |
| Nov 25, 2025 | Canaccord Genuity | down | Buy | Hold |
| Nov 24, 2025 | Benchmark | down | Buy | Hold |
| Nov 24, 2025 | Jefferies | down | Buy | Hold |
About Exact Sciences Corporation
Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the Oncotype DX family of gene expression tests, designed for breast, prostate, and colon cancers. Within this suite, the Oncotype Test provides detailed tumor profiling from tissue samples, assisting in treatment selection for individuals battling advanced, metastatic, refractory, or recurrent cancers. Furthermore, they offer the Oncotype DX AR-V7 Nucleus Detect Test, a liquid biopsy designed for advanced-stage prostate cancer patients, and Oncomap ExTra, which delivers a comprehensive biological insight into challenging, rare, or aggressive malignancies. Exact Sciences also provides COVID-19 testing services. Future initiatives involve enhancing Cologuard's performance characteristics and pioneering novel blood- and other fluid-based diagnostic tests. The company maintains important license agreements with the MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, Exact Sciences Corporation's corporate headquarters are located in Madison, Wisconsin.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
- Employees
- 6,900
- Website
- exactsciences.com
News
- Amalgam Announces Privia Health-Led Colorectal Cancer Screening Program Demonstrates 84% Screening Rates In 2024, Surpassing 80% Goal
- Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday
- Alphabet, Exact Sciences, And Regeneron Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 17-Nov. 21): Are the Others in Your Portfolio?
- Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle
- Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday
- Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
- Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
- Earnings Scheduled For November 3, 2025
Your note
Sign in to keep a note on EXAS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARANICK BRIAN | Officer | Stock Award(Grant) | Mar 22, 2026 | 0 |
| BARBER MICHAEL J | Director | Stock Award(Grant) | Jun 11, 2025 | 13,136 |
| BLOOMER AARON | Chief Financial Officer | Stock Award(Grant) | Mar 22, 2026 | 0 |
| CONDELLA SARAH K | Officer | Stock Award(Grant) | Mar 22, 2026 | 0 |
| CONROY KEVIN T | Chief Executive Officer | Stock Award(Grant) | Mar 22, 2026 | 0 |
| DOYLE JAMES EDWARD | Director | Sale | Oct 8, 2025 | 57,962 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.12% | 17,415,415 | 1.83B | Dec 30, 2025 |
| Blackrock Inc. | 7.93% | 15,134,118 | 1.59B | Dec 30, 2025 |
| HBK Investments L P | 4.01% | 7,646,637 | 802.21M | Dec 30, 2025 |
| Pentwater Capital Management Lp | 3.80% | 7,250,000 | 760.60M | Dec 30, 2025 |
| State Street Corporation | 2.19% | 4,183,039 | 438.84M | Dec 30, 2025 |
| Balyasny Asset Management LP | 2.14% | 4,089,977 | 429.08M | Dec 30, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 5,974,008 | 626.73M | Dec 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.25% | 4,299,432 | 451.05M | Dec 30, 2025 |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | 1.93% | 3,676,635 | 385.72M | Nov 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.27% | 2,425,894 | 254.50M | Dec 30, 2025 |
| Vanguard Explorer Fund | 1.07% | 2,038,358 | 213.84M | Oct 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07% | 2,041,854 | 214.21M | Dec 30, 2025 |